Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SGLT2-IN-1
Cat. No.:
OB0425LY-264
Appearance:
Solid
Purity:
99.51%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
SGLT2-IN-1 is a potent sodium-dependent glucose cotransporter (SGLT2) inhibitor that reduces glucose reabsorption by inhibiting SGLT2 protein in renal tubular epithelial cells.
Synonyms:
864070-37-1; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Dapagliflozin metabolite M8; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-hydroxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
CAS No.:
864070-37-1
Compound CID:
44580555
Formula:
C19H21ClO6
Formula Weight:
380.82
Specification
Target:
SGLT
Pathway:
Membrane transporter/Ion channel
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
SGLT2-IN-1 can be used to improve insulin sensitivity, help with weight control and reduce cardiovascular risk.
